Do patients with non‐radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?

…, M Igelmann, L Kalthoff, C Klink, D Krause… - Arthritis care & …, 2012 - Wiley Online Library
Objective Patients with axial spondylarthritis (SpA) who have structural changes in the
sacroiliac joints and/or the spine have been classified as having ankylosing spondylitis (AS), …

Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis

D Krause, B Schleusser, G Herborn… - Arthritis & Rheumatism …, 2000 - Wiley Online Library
Objective This study investigated whether efficacious methotrexate (MTX) treatment has an
impact on mortality of patients with severe rheumatoid arthritis (RA). Methods In this …

Rituximab in the treatment of Jo1 antibody–associated antisynthetase syndrome: Anti-Ro52 positivity as a marker for severity and treatment response

…, R Max, HM Lorenz, U Wagner, D Krause… - The Journal of …, 2016 - jrheum.org
Objective. Rituximab (RTX) has been used successfully for the treatment of severe Jo1
antibody-associated antisynthetase syndrome. The aim of this retrospective study was to evaluate …

Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial …

…, F Dybowski, M Igelmann, L Kalthoff, D Krause… - …, 2016 - academic.oup.com
Objective. NSAIDs are first-line therapy in axial SpA (axSpA). The proportion of patients
responding to NSAIDs and differences between AS and non-radiographic axSpA (nr-axSpA) in …

Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed …

K Janke, K Biester, D Krause, B Richter, C Schürmann… - bmj, 2020 - bmj.com
Objective To assess the comparative effectiveness of biological medicines in rheumatoid
arthritis in sufficiently similar patient populations, based on the current definitions of key …

Patients with fibromyalgia rarely fulfil classification criteria for axial spondyloarthritis

…, F Dybowski, M Igelmann, L Kalthoff, D Krause… - …, 2018 - academic.oup.com
Background The Assessments of Spondyloarthritis international Society (ASAS) classification
criteria for axial spondyloarthritis (axSpA) have been criticized because of insufficient …

[HTML][HTML] Potentially inappropriate medication including drug-drug interaction and the risk of frequent falling, hospital admission, and death in older adults-results of a …

T Reinhild Haerig, D Krause… - Frontiers in …, 2023 - frontiersin.org
Introduction: With growing age, multiple chronic diseases may result in polypharmacy. Drugs
that should be avoided in older adults are called potentially inappropriate medications (PIM)…

[HTML][HTML] Reduction of potentially inappropriate medication in the elderly: Results of a cluster-randomized, controlled trial in German primary care practices (RIME)

H Rudolf, U Thiem, K Aust, D Krause… - Deutsches Ärzteblatt …, 2021 - ncbi.nlm.nih.gov
Background Medications with an unfavorable risk–benefit profile in the elderly, and for
which there are safer alternatives, are designated as potentially inappropriate medications (PIM). …

[HTML][HTML] The efficacy of short‐term bridging strategies with high‐and low‐dose prednisolone on radiographic and clinical outcomes in active early rheumatoid arthritis …

D Krause, A Mai, R Klaassen‐Mielke… - Arthritis & …, 2022 - Wiley Online Library
Objective In active early rheumatoid arthritis (RA), glucocorticoids are often used for bridging,
due to the delayed action of methotrexate. This study was undertaken to compare the effect …

The risk of peripheral artery disease in older adults-seven-year results of the getABI study

D Krause, I Burghaus, U Thiem, US Trampisch… - Vasa, 2016 - econtent.hogrefe.com
Background: To assess the risk of peripheral artery disease (PAD) in older adults and the
contribution of traditional and novel risk factors to the incidence of PAD. Patients and methods: …